Baudax Bio, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2018 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Baudax Bio, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2018 to Q3 2023.
  • Baudax Bio, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2023 was -$1.93M, a 93.4% increase year-over-year.
  • Baudax Bio, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2023 was -$7.15M, a 64.4% increase year-over-year.
  • Baudax Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$58.8M, a 197% decline from 2021.
  • Baudax Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$19.8M, a 74% increase from 2020.
  • Baudax Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$76.1M, a 134% decline from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$7.15M -$1.93M +$27.3M +93.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-20
Q2 2023 -$34.4M -$7.38M +$156K +2.07% Apr 1, 2023 Jun 30, 2023 10-Q 2023-11-20
Q1 2023 -$34.6M $11.4M +$24.2M Jan 1, 2023 Mar 31, 2023 10-Q 2023-11-20
Q4 2022 -$58.8M -$9.25M -$38.7M -131% Oct 1, 2022 Dec 31, 2022 8-K 2023-06-28
Q3 2022 -$20.1M -$29.2M -$12.2M -72.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 -$7.87M -$7.53M +$7.8M +50.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-20
Q1 2022 -$15.7M -$12.8M +$4.1M +24.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-20
Q4 2021 -$19.8M $29.4M +$46.5M Oct 1, 2021 Dec 31, 2021 8-K 2023-06-28
Q3 2021 -$66.2M -$17M -$28.6M -245% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$37.6M -$15.3M +$15.1M +49.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-08
Q1 2021 -$52.7M -$16.9M +$23.4M +58% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-08
Q4 2020 -$76.1M -$17M -$9.72M -133% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-16
Q3 2020 -$66.4M $11.7M +$22M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$88.4M -$30.4M -$19.9M -188% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-04
Q1 2020 -$68.5M -$40.3M -$36M -830% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-04
Q4 2019 -$32.6M -$7.33M +$9.36M +56.1% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-16
Q3 2019 -$41.9M -$10.3M +$8.78M +46% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$50.7M -$10.6M +$9.86M +48.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-09
Q1 2019 -$60.5M -$4.34M +$13.1M +75.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-09
Q4 2018 -$73.7M -$16.7M Oct 1, 2018 Dec 31, 2018 10-K 2020-02-13
Q3 2018 -$19.1M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$20.4M Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-14
Q1 2018 -$17.5M Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.